ArticleChemical biology & drug design2025

Identification of a Selective Cell-Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure-Based Virtual Screening.

TongXiang Diao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.